Skip to content

Chinese Medicine Treat for Hypertensive Renal Injury

Qianyangyuyin Formula Prevent and Treat for Early Renal Injury in Hypertensive Patients

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04078711
Acronym
CHAIR
Enrollment
520
Registered
2019-09-06
Start date
2019-09-10
Completion date
2021-12-30
Last updated
2019-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Renal Injury

Keywords

hypertension, chronic kidney disease, traditional chinese medicine, early renal injury, albumin to creatinine ratio(UACR)

Brief summary

This study evaluates whether the traditional chinese medicine (Qianyangyuyin formula) could prevent and treat early renal injury in patients with hypertension and microalbuminuria (defined as a urinary albumin to creatinine ratio between 30 and 300 mg/g) based on standard antihypertensive treatment.

Detailed description

Hypertension is the main cardiovascular disease and the most important risk factor for severe lethal and disabling diseases such as stroke, myocardial infarction, heart failure, and chronic renal insufficiency. The higher the blood pressure level, the higher the risk of these diseases. Antihypertensive drugs can control blood pressure, and effectively reduce the risk of these serious complications. A multi-center, randomized, parallel, placebo-controlled clinical study was designed to explore the effectiveness and safety of early intervention of Chinese medicine (Qianyanguuyin formula) in improving urinary albumin to creatinine ratio (ACR), based on standard antihypertensive treatment (losartan 100mg qd, if necessary combined with calcium channel blockers). Patients were recruited if they were (1) age between 35 and 55 years old, (2) primary hypertension (grades 2-3 ), (3) microalbuminuria (ACR of 30-300 mg/g) and eGFR of at least 60 ml / (min∙1.73m2), (4) ascendant hyperactivity of liver Yang or Yin deficiency in TCM syndrome. It's intented to form a standardized plan for the prevention and treatment of early renal injury in hypertensive patients.

Interventions

DRUGLosartan 100Mg Tab

100Mg Tab, qd, po, 6 months

DRUGQianyangyuyin 20g Granule

20g, Granule, bid, po, 6 months

DRUGplacebo

Similar granule manufactured to mimic qianyangyuyin granule, 20g, Granule, bid, po, 6 months

Sponsors

Ministry of Science and Technology of the People´s Republic of China
CollaboratorOTHER_GOV
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
CollaboratorOTHER
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
CollaboratorOTHER
Jiangsu Province Hospital of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
35 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Subject has primary hypertension(grades 2-3) * Subject has microalbuminuria \[defined as a urinary albumin/creatinine ratio (UACR) between 30 and 300mg/g, and a eGFR at least 60ml/(min∙1.73m2)\] * Subject has ascendant hyperactivity of liver Yang or Yin deficiency in TCM syndrome * Subject voluntarily participates in the trial and signs informed consent

Exclusion criteria

* Subject has secondary hypertension * Subject with pregnancy or lactating * Subject has serious life-threatening diseases, such as acute myocardial infarction, stroke, heart failure (NYHA IV), and malignant arrhythmia * Subject's liver function (AST or ALT) is 2 times greater than normal value * Subject has history of mental illness * Subject currently participates in other drug clinical trials

Design outcomes

Primary

MeasureTime frameDescription
albumin-to-creatinine ratio(UACR)6 monthsUACR tested at baseline and each month. Microalbuminuria was defined as urinary ACR of at least 30mg/g.

Secondary

MeasureTime frameDescription
Ambulatory blood pressure level6 monthsABPM was measured at baseline, 3 and 6 months. Both systolic and diastolic pressure was assessed. Hypertension was defined as mean ambulatory blood pressure of at least 130/80 mmHg.
Office blood pressure level 6/5000 Office blood pressure level6 monthsOffice blood pressure was measured at baseline and each month. Both systolic and diastolic pressure was assessed. Hypertension was defined as office blood pressure of at least 140/90 mmHg.
Traditional Chinese Medicine syndrome scores6 monthsSelf reported TCM syndrome scores at baseline and each month. Each main symptom is scored 0、2、4、6 (0 = no sympton; 6 = as heavy as can be), and each secondary symptom is scored 0、1、2、3(0=no symptom; 3= as heavy as can be).

Contacts

Primary ContactMing Liu
liumingxinghua@163.com13815885859

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026